Article

Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia.

Infectious Diseases Unit, The Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria 3181, Australia.
European Journal of Clinical Microbiology (impact factor: 2.86). 07/2005; 24(6):384-7. DOI:10.1007/s10096-005-1329-3 pp.384-7
Source: PubMed

ABSTRACT Eight patients with invasive bacteremic community-acquired methicillin-resistant Staphylococcus aureus infection in southeast Queensland, Australia, are reported. One patient died of septic shock. Haematogenous seeding to lungs, bone, and other sites was common. All isolates carried the virulence factor Panton-Valentine leukocidin and were either the southwest Pacific clone or the newly described Queensland clone. Clinicians should consider community-acquired methicillin-resistant Staphylococcus aureus infection in any patient presenting to hospital with severe staphylococcal sepsis or pneumonia.

0 0
 · 
0 Bookmarks
 · 
42 Views
  • Source
    Article: Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000-2006: use of passive surveillance of susceptibility phenotypes.
    G R Nimmo, J Fong, D L Paterson, M-L McLaws
    [show abstract] [hide abstract]
    ABSTRACT: The epidemiology of meticillin-resistant S. aureus (MRSA) infection has changed remarkably in recent years with the appearance of new MRSA strains causing infections in the community. These strains have now begun to cause healthcare-associated infections. The ability to track such changes is necessary to guide clinical and public health action. Here we report passive surveillance of all public laboratory susceptibility data in Queensland to track changes in MRSA phenotypes corresponding to the major epidemic strains from 2000 to 2006. The inpatient rate of MRSA isolation from pus, tissue and fluid (PTF) and blood culture (BC) specimens declined by 26% and 35%, respectively. The rate of isolation of the AUS-2/3-like phenotype (corresponding to ST239-MRSA-III) decreased from 651 to 242 isolates per million accrued patient days in inpatient PTF and BC, whereas that for non-multiresistant MRSA (nmMRSA, corresponding to community MRSA strains) increased from 71 to 315. The overall outpatient rate of MRSA isolation from PTF and BC increased by 224% and 31%, respectively. The rate of AUS-2/3-like isolates in outpatient PTF decreased from 131 to 60 per million outpatient occasions of service while the nmMRSA rate increased from 52 to 490. Surveillance of phenotypes derived from routine susceptibility data is a useful tool for tracking changes in the epidemiology of MRSA over large geographical regions.
    Journal of Hospital Infection 10/2008; 70(4):305-13. · 3.39 Impact Factor
  • Source
    Article: Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.
    Kyra Chua, Frederic Laurent, Geoffrey Coombs, M Lindsay Grayson, Benjamin P Howden
    [show abstract] [hide abstract]
    ABSTRACT: There is significant diversity in methicillin-resistant Staphylococcus aureus (MRSA) clones arising in the community worldwide, with considerable geographical differences in typical antimicrobial resistance profiles. Many community clones of MRSA have a non-multidrug resistant antimicrobial profile, providing increased options for empirical and directed therapy of infections caused by these strains. However, the recent description of increasing non-β lactam resistance in community clones of MRSA, especially USA300, provides a timely warning for clinicians making decisions about therapy for patients potentially infected with these strains. Continued monitoring of global epidemiology and emerging drug resistance data is critical for the effective management of these infections.
    Clinical Infectious Diseases 01/2011; 52(1):99-114. · 9.15 Impact Factor
  • Source
    Article: Treatment of complicated skin and soft tissue infections.
    Addison K May, Renae E Stafford, Eileen M Bulger, Daithi Heffernan, Oscar Guillamondegui, Grant Bochicchio, Soumitra R Eachempati
    [show abstract] [hide abstract]
    ABSTRACT: Skin and soft tissue infections (SSTIs) may produce substantial morbidity and mortality rates, particularly those classified as complicated or necrotizing. To weigh the strength of recommendations using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) methodology and to provide evidence-based recommendations for diagnosis and management for SSTIs. Computerized identification of published research and review of relevant articles. All published reports on the management of complicated and necrotizing SSTIs were evaluated by an expert panel of members of the Surgical Infection Society according to published guidelines for evidence-based medicine. The quality of the evidence was judged by the GRADE methodology and criteria. Practice surveys, pharmacokinetic studies, and reviews or duplicative publications presenting primary data already considered were excluded from analysis. DATA EXTRACtion: Information on demographics, study dates, microbiology findings, antibiotic type, surgical interventions, infection-related outcomes, and the methodologic quality of the studies was extracted. Results were submitted to the Therapeutic Agents Committee of the Surgical Infection Society for review prior to creation of the final consensus document. Current surgical and antibiotic management of complicated SSTIs is based on a small number of studies that often have insufficient power to draw well-supported conclusions, with the exception of antimicrobial therapy for non-necrotizing soft tissue infections, for which ample data are available.
    Surgical Infections 10/2009; 10(5):467-99. · 1.80 Impact Factor

Show more

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

community-acquired methicillin-resistant Staphylococcus aureus infection
 
described Queensland clone
 
Haematogenous seeding
 
invasive bacteremic community-acquired methicillin-resistant Staphylococcus aureus infection
 
septic shock
 
severe staphylococcal sepsis
 
virulence factor Panton-Valentine leukocidin